NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Predicta Biosciences

Predicta Biosciences

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://www.predictabiosciences.com/

Last Round

Series A

Oct 1, 2025

Total Funding Raised

$28.6M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Predicta Biosciences is a biotechnology company that has developed an oncology technology platform designed for cancer diagnosis and treatment, specializing in integrating multi-omics and liquid biopsy technologies.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Biotechnology, Medical Devices

Business Model

B2B

Customer Profile

Usage-Based SaaS, Data as a Service

AI Layer

Application

Keywords

precision oncologycancer diagnosticsgenomic testingliquid biopsylaboratory developed testLDTmultiomic datacancer researchbiotechdrug discoveryclinical diagnosticsdiagnostic kittumor profilingprecision medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Predicta Biosciences Comparables

Compare Predicta Biosciences with similar companies based on industry and business-model similarity.

Predicta Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Predicta Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AOct 1, 2025
SeedJul 16, 2024

Predicta Biosciences Investors

Notable investors and investment history

Predicta Biosciences investors
InvestorRounds
Engine VenturesSeed, Series A
Binney Street CapitalSeries A
Mass General Brigham InnovationSeries A
Mass General Brigham VenturesSeries A
BrightEdgeSeed, Series A
Engine VenturesSeed, Series A
Time Boost Capital I LPSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 15, 2026

    Launched GenoPredicta test kit in partnership with Tempus AI.

  • Apr 15, 2026

    Partnered with Tempus AI Inc. for the launch of GenoPredicta test kit.

Predicta Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Predicta Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Predicta Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range20
Year Founded2023
Last FundingOct 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.